CSD-Induced Arterial Dilatation and Plasma Protein Extravasation Are Unaffected by Fremanezumab: Implications for CGRP's Role in Migraine with Aura.

Saved in:
Bibliographic Details
Title: CSD-Induced Arterial Dilatation and Plasma Protein Extravasation Are Unaffected by Fremanezumab: Implications for CGRP's Role in Migraine with Aura.
Authors: Schain AJ; Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Boston MA 02115.; Harvard Medical School, Boston, Massachusetts 02215, and., Melo-Carrillo A; Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Boston MA 02115.; Harvard Medical School, Boston, Massachusetts 02215, and., Stratton J; Teva Biologics, Redwood City, California 94063., Strassman AM; Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Boston MA 02115.; Harvard Medical School, Boston, Massachusetts 02215, and., Burstein R; Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Boston MA 02115, rburstei@bidmc.harvard.edu.; Harvard Medical School, Boston, Massachusetts 02215, and.
Source: The Journal of neuroscience : the official journal of the Society for Neuroscience [J Neurosci] 2019 Jul 24; Vol. 39 (30), pp. 6001-6011. Date of Electronic Publication: 2019 May 24.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Society for Neuroscience Country of Publication: United States NLM ID: 8102140 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1529-2401 (Electronic) Linking ISSN: 02706474 NLM ISO Abbreviation: J Neurosci Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1529-2401
DOI:10.1523/JNEUROSCI.0232-19.2019